PSMA and 18F-FDG PET Imaging in the Treatment of Metastatic Prostate Cancer with 223Ra: Initial Application and Experience

PSMA and 18F-FDG PET Imaging in the Treatment of Metastatic Prostate Cancer with 223Ra: Initial Application and Experience

Objective  To share our experience of the use of prostate specific membrane antigen (PSMA) and/or 18F-fluoroodexyglucose (18F-FDG) positron emission tomography (PET) in the setting of radium-223 dichloride (223Ra) in treatment of bone metastases of prostate cancer in order to broaden the know-ledge...

Full description

Bibliographic Details
Main Authors: HU Guilan, TIAN Jian, LI Yongqiang, JI Zhigang, HUO Li, CHEN Yonghui
Format: Article
Language:zho
Published: Editorial Office of Medical Journal of Peking Union Medical College Hospital 2023-07-01
Series:Xiehe Yixue Zazhi
Subjects:
prostate cancer
radium-223 dichloride
prostate specific membrane antigen
fdg
Online Access:https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2023-0152

Internet

https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2023-0152

Similar Items